Ameriprise
BMEZ icon

Ameriprise’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Ameriprise’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Buy
27,544
+2,546
+10% +$36.6K ﹤0.01% 3712
2026
Q1 		$359K Buy
24,998
+1,979
+9% +$29.4K ﹤0.01% 3705
2025
Q4 		$346K Sell
23,019
-426
-2% -$6.4K ﹤0.01% 3763
2025
Q3 		$338K Buy
23,445
+8,924
+61% +$127K ﹤0.01% 3760
2025
Q2 		$212K Buy
14,521
+1,787
+14% +$25.5K ﹤0.01% 3796
2025
Q1 		$190K Sell
12,734
-13,155
-51% -$206K ﹤0.01% 3805
2024
Q4 		$373K Sell
25,889
-3,163
-11% -$49K ﹤0.01% 3635
2024
Q3 		$460K Sell
29,052
-22,190
-43% -$350K ﹤0.01% 3510
2024
Q2 		$787K Sell
51,242
-10,808
-17% -$164K ﹤0.01% 3254
2024
Q1 		$1.02M Sell
62,050
-13,341
-18% -$210K ﹤0.01% 3159
2023
Q4 		$1.1M Sell
75,391
-6,549
-8% -$91.4K ﹤0.01% 3142
2023
Q3 		$1.18M Sell
81,940
-87,583
-52% -$1.37M ﹤0.01% 3065
2023
Q2 		$2.78M Sell
169,523
-9,248
-5% -$151K ﹤0.01% 2709
2023
Q1 		$2.99M Buy
178,771
+3,763
+2% +$60.6K ﹤0.01% 2642
2022
Q4 		$2.7M Buy
175,008
+487
+0.3% +$7.54K ﹤0.01% 2671
2022
Q3 		$2.6M Buy
174,521
+8,083
+5% +$134K ﹤0.01% 2659
2022
Q2 		$2.74M Buy
166,438
+93,221
+127% +$1.6M ﹤0.01% 2678
2022
Q1 		$1.46M Buy
73,217
+24,332
+50% +$505K ﹤0.01% 3052
2021
Q4 		$1.24M Buy
48,885
+20,521
+72% +$530K ﹤0.01% 3158
2021
Q3 		$765K Buy
28,364
+5,546
+24% +$159K ﹤0.01% 3269
2021
Q2 		$660K Sell
22,818
-96,588
-81% -$2.67M ﹤0.01% 3363
2021
Q1 		$3.13M Buy
119,406
+15,153
+15% +$430K ﹤0.01% 2667
2020
Q4 		$2.99M Sell
104,253
-34,951
-25% -$929K ﹤0.01% 2594
2020
Q3 		$3.32M Buy
139,204
+7,337
+6% +$169K ﹤0.01% 2360
2020
Q2 		$2.72M Buy
+131,867
New +$2.6M ﹤0.01% 2446

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Ameriprise's BMEZ Position: Q2 2026 in Review

Ameriprise increased its BlackRock Health Sciences Trust II (BMEZ) stake by 10% in Q2 2026, buying an estimated $36.6K and bringing the position to 27,544 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #3712.

Ameriprise first reported a position in BMEZ in Q2 2020 and has held it in 25 quarters since. The position peaked at $3.32M in Q3 2020. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Ameriprise held 27,544 shares of BlackRock Health Sciences Trust II worth $423K as of Q2 2026.
  • Ameriprise bought 2,546 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $36.6K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3712 holding.
  • Ameriprise first reported a position in BlackRock Health Sciences Trust II in Q2 2020 and has held it in 25 quarters since.
  • Ameriprise's BlackRock Health Sciences Trust II position peaked at $3.32M in Q3 2020.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.